AI tool successfully predicts outcomes of immunotherapy in lung cancer
Peer-Reviewed Publication
Peer-Reviewed Publication
Latest News Releases
Updates every hour. Last Updated: 1-Nov-2026 08:16 ET (1-Nov-2026 13:16 GMT/UTC)
Peer-Reviewed Publication
Identification PDF as a biomarker of “cold” CRC using integrated bioinformatics and machine learning
Peer-Reviewed Publication
Researchers identify ANKRD11 as a brake on T-cell responses to chronic hepatitis B virus and cancer
Peer-Reviewed Publication
Phase 3 DESTINY-Lung04 trial shows first-line trastuzumab deruxtecan significantly improves progression-free survival in HER2-mutant NSCLC
Reports and Proceedings
Zipalertinib plus chemotherapy significantly extends progression-free survival in first-line EGFR exon 20 insertion-positive NSCLC
Reports and Proceedings
Eight-year ADAURA update shows sustained overall survival benefit with adjuvant osimertinib in resected EGFR-mutated NSCLC
Reports and Proceedings
Zidesamtinib demonstrates 94% response rate in TKI-naive patients with advanced ROS1-positive NSCLC
Reports and Proceedings
In the PAPILLON study, first-line amivantamab-chemotherapy demonstrates the longest overall survival reported for EGFR exon 20 insertion-positive advanced NSCLC
Reports and Proceedings
New analysis points to low overdiagnosis in breast cancer screening
Peer-Reviewed Publication
Phase III MAVERICK trial supports brain MRI surveillance alone as standard of care for small-cell lung cancer
Reports and Proceedings